Project Grant HT94252410059
Award Date
5/1/24
Completion Date
4/30/26
Dollars Obligated
$200K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
France
Similar Awards
Institut National De La Sante Et De La Recherche Medicale Delegation Regionale Paris-Idf Centre-Est (INSERM) received a $502,550 project grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support medical research related to Neurofibromatosis Type 1 and associated bone abnormalities from June 1, 2023 to May 31, 2026. INSERM has also received three federal sub-awards totaling $75,000 to support the development of focused...
The U.S. Defense Health Agency has awarded a $602,800 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Vlaams Instituut Voor Biotechnologie (VIB), a non-profit research institute in Belgium. The grant, effective September 1, 2024 through August 31, 2027, will fund VIB's research on a "Reduced Combination of Genetic Variants to Predict and Stratify Alzheimer's Disease." This project aims to advance medical solutions for neurodegenerative...
The Institut Curie, a foreign-owned non-profit organization in France, has been awarded a $1,907,499 Project Grant from the U.S. Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from September 30, 2023 to September 29, 2027, supports the Institut Curie's research on genetic predispositions and tumor markers for uveal melanoma, the most common eye cancer in adults. Specifically, the Institut Curie is conducting...
This $761,027 federal Project Grant award, issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, will support research at Montclair State University to model hemangioblastomas using induced pluripotent stem cells carrying mutations in the von Hippel-Lindau gene. The project aims to advance understanding and treatment of this rare form of brain tumor, which disproportionately impacts military personnel and veterans. The award has a...
The U.S. Defense Health Agency has awarded a $367,622 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to St. Vincent's Institute of Medical Research, a foreign-owned non-profit organization based in Australia. The grant supports a 2-year research project focused on studying the reprogramming of mRNA translation as a driver of drug resistance in ovarian cancer. The research aims to transform healthcare for military service members and the broader public...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
This $485,597.91 federal Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support research at the Universite De Sherbrooke in Canada. The award will fund a 3-year project from August 1, 2024 to July 31, 2027 focused on understanding the "CONTRIBUTION OF ALTERNATIVE SPLICING TO NEUROFIBROMAGENESIS." The research aims to advance scientific knowledge in the area of neurological disorders, which...
The U.S. Department of Defense's Defense Health Agency (DHA) awarded a $750,000 Project Grant to Stanford University to implement a spatial and single-cell multiplexed platform for the development of targeted therapies for vascularized composite allotransplantation. The funding is provided through the Military Medical Research and Development (CFDA 12.420) federal grant program, which supports advanced biomedical research to transform healthcare for military service members and the broader...
This Project Grant award of $568,114.00 from the Defense Health Agency was made to Ecole Polytechnique Fédérale De Lausanne (EPFL), a university in Lausanne, Switzerland, to conduct research and development related to baroprosthesis to reduce secondary damage of traumatic spinal cord injury. The award was made under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform healthcare for Service Members and the public. The research...
The U.S. Defense Health Agency awarded a $1,213,276 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective September 1, 2023 through August 31, 2026, will fund research on the role of vascular mimicry in the outgrowth of dormant melanoma micrometastases. The goal of this research is to transform health care for Service Members and the American public through innovative and impactful medical research on solutions...